Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2014

Nov 3, 2014

30718_dirs_2014-11-03_593e6815-4045-4242-a446-0099c4546ed4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2014-10-30

Reporting Person: WIENS HAROLD J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-10-30 Common Stock A 1000 Acquired 1500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-10-30 Stock Option (right to buy) $91.78 A 4000 Acquired 2024-10-30 Common Stock (4000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $87.83 2024-05-15 Common Stock (2000) 2000 Direct